Head and Neck Cancer Market is estimated to grow at a CAGR of 9.5% through the forecast period 2017 to 2023
Head
and Neck Cancer Market Research Report: By type (Laryngeal, Pharyngeal,
Salivary Gland, Oral Cavity, Nasopharyngeal), by Diagnosis (Blood Test,
Endoscopy, others), by Treatment (Chemotherapy, Surgery, Others), by End-User –
Global Forecast Till 2027
Head and Neck Cancer Market Highlights
It is estimated that the head and neck cancer market is
expected to grow at a CAGR 9.5%
during the forecast period of 2017–2023.
The incidence of cancer has
grown rapidly over the past few years at an alarming rate, among which head and
neck cancer has a huge chunk. Reports that evaluate the medical device industry
have been made accessible by Market Research Future, which creates reports on
several industry verticals that review the market development and prospects.
The surge in alcohol and
tobacco consumed globally is often cited as a key factor contributing to the
head and neck cancers. Increased detection of cancer due to the development of
medical expertise and devices is projected to encourage the market in the
forecast period. Substantial
developments seen in the oncology field are expected to improve the treatment
methods for this type of cancer and will open up new avenues for market
progress in the approaching period.
Segmental
Analysis
The segmentation of the head
and neck cancer market is conducted on the basis of the type of head and neck
cancer, diagnosis, region, treatment type, and end-user. Based on the type of
head and neck cancer, the market is segmented into laryngeal cancer, salivary
gland cancer, pharyngeal cancer, nasopharyngeal cancer, lip and oral cavity
cancer, and others. By diagnosis, the market for hand and neck cancer is
segmented into blood tests, bioscopy screening tests, dental diagnosis, and
endoscopy. Based on treatment type, the head and neck cancer market is
segmented into surgery, radiation therapy, chemotherapy, targeted therapy, and
others. The radiation therapy is additionally segmented into internal radiation
therapy and external beam radiation. By end-users, the market is segmented into
specialty clinics, hospitals, and ambulatory surgical centers.
Request
Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/5798
Detailed
Regional Analysis
The regional assessment of the
head and neck cancer market comprises of regions such as the Americas, Europe,
Middle East, Asia Pacific, and Africa. The Americas region dominates the head
and neck cancer market due to the incidence of a major patient population,
growing prevalence of head and neck cancer, sophisticated technology, high
healthcare spending, and the incidence of chief market companies. Approximately
3% of all the cancers in the USare head and neck cancer cases. The European
region holds the next position in the global head and neck cancer market. It is
anticipated that the research and development spending offered by the
government and private organizations, growing competition among marketers,
growing healthcare expenses, and adjustments in reimbursement policies in
healthcare are expected to guide the European region’s head and neck cancer
market. The Asia Pacific region is a rapidly increasing head and neck cancer
market due to an enormous patient pool, growing demand, and the advancement of
healthcare technology. The Middle East and Africa region retain the least share
of the head and neck cancer market globally due to low growth, deficiency of
technical knowledge, and impoverished medical facilities.
Competitive
Analysis
The disequilibrium noticed in
the forces that are backing the growth of the market is expected to lead to a
relatively slow pace of the growth. The global economies are reacting to the
market forces by implementing favorable policies and cutbacks so as to prevent
a slowdown in the progress of the market. The changes in the income levels
globally are contributing to the growth of the market. The rise in individual
discretionary spending is anticipated to lead to the progress of the market.
The enhancement of the distribution channels is projected to motivate market
growth relatively. The conducive nature of the monetary and fiscal policies is
likely to lead to solid growth in the market. Moreover, the rise in
International transactions is anticipated to bolster the expansion of the
market considerably. The positive effect of the governments in the development
of the market is expected to guide the market towards sound progress in the
coming years.
The significant contenders in
the head and neck cancer market are AbbVie Inc., Acceleron Pharma, Inc., AdDent
Inc., ASAHI Roentgen, Astellas Pharma Inc., AB Science SA, Bayer AG, Siemens
Healthcare, Boston Biomedical, Inc., Bristol-Myers Squibb Company, Carestream,
GE Healthcare, AstraZeneca Plc., Koninklijke Philips N.V., Identafi, NeuSoft,
Shimadzu Corporation, Fujifilm Holdings, Varian Medical Systems, Xoran, and
others.
Browse Detailed TOC with
COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/head-and-neck-cancer-market-5798
About
Market Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment